Exploring Analyst Estimates for FMC (FMC) Q4 Earnings, Beyond Revenue and EPS

03.02.25 15:16 Uhr

Werte in diesem Artikel
Aktien

37,16 EUR 0,11 EUR 0,30%

43,83 EUR 0,32 EUR 0,74%

Indizes

PKT PKT

1.967,6 PKT -35,5 PKT -1,77%

23.008,9 PKT -410,5 PKT -1,75%

8.813,8 PKT -157,3 PKT -1,75%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

211,4 PKT -2,0 PKT -0,91%

563,4 PKT -5,1 PKT -0,90%

12.047,3 PKT -217,4 PKT -1,77%

23.205,0 PKT 18,0 PKT 0,08%

23.080,2 PKT -151,7 PKT -0,65%

8.898,9 PKT -162,2 PKT -1,79%

17.454,4 PKT -286,2 PKT -1,61%

1.854,4 PKT -8,4 PKT -0,45%

5.770,2 PKT 31,7 PKT 0,55%

Wall Street analysts forecast that FMC (FMC) will report quarterly earnings of $1.61 per share in its upcoming release, pointing to a year-over-year increase of 50.5%. It is anticipated that revenues will amount to $1.32 billion, exhibiting an increase of 15.5% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.That said, let's delve into the average estimates of some FMC metrics that Wall Street analysts commonly model and monitor.The consensus estimate for 'Geographic Revenue- Latin America' stands at $516.98 million. The estimate points to a change of +19.5% from the year-ago quarter.Analysts expect 'Geographic Revenue- Europe, Middle East and Africa (EMEA)' to come in at $183.05 million. The estimate suggests a change of +14.7% year over year.Analysts' assessment points toward 'Geographic Revenue- Asia' reaching $273.66 million. The estimate suggests a change of -1.7% year over year.Based on the collective assessment of analysts, 'Geographic Revenue- North America' should arrive at $347.53 million. The estimate points to a change of +26.2% from the year-ago quarter.View all Key Company Metrics for FMC here>>>Over the past month, shares of FMC have returned +14.9% versus the Zacks S&P 500 composite's +2.7% change. Currently, FMC carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
04.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
04.03.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
27.02.2025Fresenius Medical Care (FMC) St HoldWarburg Research
27.02.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
26.02.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
27.02.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
25.02.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
30.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
21.01.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
04.03.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
27.02.2025Fresenius Medical Care (FMC) St HoldWarburg Research
26.02.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
25.02.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
25.02.2025Fresenius Medical Care (FMC) St HoldWarburg Research
DatumRatingAnalyst
04.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
26.02.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
25.02.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
25.02.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
14.02.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"